KALV

KALV

USD

KalVista Pharmaceuticals Inc. Common Stock

$10.850-0.130 (-1.184%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$10.980

Haut

$11.100

Bas

$10.630

Volume

0.87M

Fondamentaux de l'Entreprise

Capitalisation Boursière

548.2M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

1.19M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $7.3Actuel $10.850Haut $17.28

Actualités Connexes

BusinessWire

KalVista Pharmaceuticals to Host Third Quarter Financial Results Conference Call and Webcast on November 11, 2025

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) will host a conference call and webcast on Tuesday, November 11, 2025, at 8:30 a.m. ET to review the Company's third quarter financial results and provide an operational

Voir plus
KalVista Pharmaceuticals to Host Third Quarter Financial Results Conference Call and Webcast on November 11, 2025
BusinessWire

KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting

KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) today announced the acceptance of one abstract for late-breaking oral presentation and three for poster presentation at the American College of Allergy, Asthma &

Voir plus
KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.